Diaprost AB
  • Diaprost AB
  • Share:
  • Subscribe:
  • news.cision.com/
  • Diaprost AB/
  • Diaprost Licenses its novel Theranostic Antibody, hu5A10, to Radiopharm Theranostics for Development in the Treatment and Diagnosis of Prostate Cancer./
  • Johan Drott CEO Diaprost AB

Johan Drott CEO Diaprost AB

Tue, Sep 28, 2021 09:00 CET

Low resolution

Medium resolution

Original resolution

Subscribe

Related Releases

Diaprost Announces Promising New Study for Patients with Metastatic PCa Mon, Feb 22, 2021 08:00 CET
Diaprost AB Acquires Rights to use of PSA Antibodies from Leading New York Cancer Center Tue, Aug 25, 2020 08:00 CET
Diaprost announces Exercise of Option under the terms of its Research and Option Agreement with a leading Pharmaceutical company Tue, Jan 21, 2020 10:50 CET
©Cision
Privacy statement | Cookies | About | Content Policy | Contact    Cision
©Cision Privacy statement Cookies About Content Policy Contact

   Cision